Effective March 3, 2021 – BCBS Policy Genotype-Guided Warfarin Dosing Updated

As of March 3, 20201

Description section updated. Title changed from Genetic Testing for Warfarin Dose to Genetic Testing for Warfarin Dose

In Policy section:

• Added “P450 4F2 (CYP42)”

• Removed “international normalized ratio”

• Removed Policy Guidelines Rationale section

In Coding section:

• Added code: 0030U

Source: https://www.bcbsks.com/CustomerService/Providers/MedicalPolicies/policies/policies/Genotype-GuidedWarfarinDosing_2021-02-10.pdf